27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- Pfizer Inc (NYSE:PFE) is reportedly exploring options for some early-stage candidates for rare diseases, including developing new viral-based gene therapies.
- Financial newspaper Barron's first reported on Thursday.
- The U.S. pharma giant said these options included collaborations with other drug developers for these medicines or establishing a new company, with an aim to focus on "high-impact" medicines and vaccines.
- Also see: Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent Expiry.
- The company said it would look for external opportunities for most of its early-stage rare disease programs in neurology, cardiology, and gene therapy programs not yet in clinical trials.
- Pfizer might chop its gene therapy manufacturing facility in Durham, North Carolina, with the decision. The company announced in December 2021 that it was investing nearly $70 million.
- Pfizer plans to focus on internally developing rare disease treatments using technologies such as gene editing, Reuters wrote citing Barron's report.
- Earlier today, the FDA accepted Pfizer's supplemental application for its 20-valent pneumococcal conjugate vaccine candidate for infants and children six weeks through 17 years.
- Pfizer in August 2022 announced a $4.5 billion deal for sickle cell disease drugmaker Global Blood Therapeutics months after its $11.6 billion deal for Biohaven Pharmaceutical Holding.
- Price Action: PFE shares are down 0.12% at $49.60 during the premarket session on the last check Friday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!